Inventor · disambiguated record
Martin Patrick Allen
Also filed as: ALLEN MARTIN P · ALLEN MARTIN PATRICK
18 granted patents·11 pending applications·198 citations·filing 1999–2023
94Inventor score
Top patents by PatentIndex Score
29 records- 0196US9308236B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 12, 2016·51 cites·5 claims
- 0295US9879046B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 30, 2018·17 cites·12 claims
- 0393US10143746B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·9 cites·17 claims
- 0492US9850283B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 26, 2017·12 cites·1 claims
- 0592US7642267B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2007·Granted Jan 5, 2010·20 cites·21 claims
- 0690US9861680B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 9, 2018·10 cites·3 claims
- 0788US9944678B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 17, 2018·8 cites·2 claims
- 0887US10450347B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 22, 2019·6 cites·23 claims
- 0987US10358463B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·7 cites·15 claims
- 1087US7268142B2Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinolinePFIZER·Filed 2005·Granted Sep 11, 2007·16 cites·16 claims
- 1185US7521464B2Pyrazole compounds for treatment of neurodegenerative disordersPFIZER·Filed 2007·Granted Apr 21, 2009·7 cites·16 claims
- 1284US10538555B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 21, 2020·8 cites·3 claims
- 1382US11492375B2Cyclic peptide immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 8, 2022·2 cites·16 claims
- 1480US7238721B2Pyrazole compounds for treatment of neurodegenerative disordersPFIZER·Filed 2003·Granted Jul 3, 2007·13 cites·18 claims
- 1569US6586431B13,3-Biarylpiperidine and 2,2-biarylmorpholine derivativesPFIZER·Filed 2000·Granted Jul 1, 2003·4 cites·1 claims
- 1666US7456177B2Heteroaryl fused azapolycyclic compoundsPFIZER·Filed 2004·Granted Nov 25, 2008·2 cites·3 claims
- 1764US2025250299A1Macrocyclic immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1863US2025163104A1Macrocyclic immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1962US2024360178A1Macrocyclic immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2061US2024409585A1Macrocyclic immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2160US2024199701A1ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2257US7300945B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2005·Granted Nov 27, 2007·0 cites·126 claims
- 2357US2017369530A1Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2452US2004063940A13,3-Biarylpiperidine and 2,2-biarylmorpholine derivativesPFIZER·Filed 2003·Application pending·0 cites
- 2551US2010267698A1Benzimidazole and Pyridylimidazole DerivativesNEUROGEN CORP·Filed 2010·Application pending·0 cites
- 2647US6503905B13,3-biarylpiperidine and 2,2-biarylmorpholine derivativesPFIZER·Filed 1999·Granted Jan 7, 2003·6 cites·8 claims
- 2745US2009023756A1Substituted quinazolines as pde10 inhibitorsPFIZER·Filed 2007·Application pending·0 cites
- 2844US2016222060A1ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2932US2012053165A1Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase ModulatorsALLEN MARTIN PATRICK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Patrick Allen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →